DRIO - CIK 0001533998
DarioHealth Corp. trades as DRIO. In its fiscal 2025 annual report the company posted revenue of $22.36M, down 17.3% from the prior year and net income of -$41.71M. This page tracks DarioHealth Corp. through 886 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years DarioHealth Corp.'s revenue grew from $2.80M to $22.36M, a compound annual growth rate of 26.0%. Net profit margin expanded from -388.4% to -186.6% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-13 |
| SD | - | 2026-05-07 |
| New insider ownership | 3 | 2026-04-13 |
| Major company event | 8-K | 2026-04-13 |
| Major company event | 8-K | 2026-03-30 |
| Prospectus supplement | 424B5 | 2026-03-30 |
| EFFECT | - | 2026-03-27 |
| Company correspondence | CORRESP | 2026-03-25 |
The largest companies sharing DarioHealth Corp.'s SEC industry classification (surgical & medical instruments & apparatus).
DarioHealth Corp. reported revenue of $22.36M for fiscal year 2025, a decrease of 17.3% year over year.
In its latest fiscal year DarioHealth Corp. reported a net loss of $41.71M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.